Enhanced Therapeutic Effect of Cytidine-5'-diphosphate Choline when Associated with GM1 Containing Small Liposomes As Demonstrated in a Rat Ischemia Model

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 1995 Nov 1

PMID 8592684

Citations 8

Authors

M Fresta

E WEHRLI

G Puglisi

Affiliations

Soon will be listed here.

Abstract

Purpose: Cytidine-5'-diphosphate choline (CDPc) was encapsulated in long-circulating unilamellar vesicles (SUVs) to improve the drug's biological effectiveness.

Methods: SUVs made up of diaplmitoylphosphatidylcholine/diaplmitoylphosphatidylserine /cholesterol (7:4:7 molar ratio) and 8 mol % of ganglioside GM1 were prepared by extrusion through polycarbonate filters (mean diameter 50 nm). The formulation effectiveness was evaluated by an in vivo model of cerebral ischemia on Wistar rats.

Results: The enhanced delivery of CDPc into the brain improved the therapeutic effectiveness of the drug. CDPc-loaded SUVs improved the survival rate of ischemized and reperfused Wistar rats (320-350 g) by approximately 66% compared with the free drug. Liposome formulation was also able to effectively protect the brain against peroxidative damage caused by post-ischemic reperfusion. SUVs lowered the conjugated diene levels of the cerebral cortex. The liposomal delivery system did not alter the distribution patterns in the various cerebral lipid fractions of the drug, radiolabeled with 14C-CDPc.

Conclusions: CDPc-loaded SUVs were able to protect the brain against damage induced by ischemia. A possible clinical application is envisaged.

Citing Articles

OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline.

dAvanzo N, Paolino D, Barone A, Ciriolo L, Mancuso A, Christiano M Drug Deliv Transl Res. 2024; 14(10):2771-2787.

PMID: 38478324 PMC: 11384645. DOI: 10.1007/s13346-024-01556-3.

Highly Stable, Ultrasmall Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability.

Hong B, Iscen A, Chipre A, Li M, Lee O, Leonard J J Phys Chem Lett. 2018; 9(5):1133-1139.

PMID: 29388774 PMC: 5990519. DOI: 10.1021/acs.jpclett.7b03312.

Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.

Trimmel H, Majdan M, Wodak A, Herzer G, Csomor D, Brazinova A Wien Klin Wochenschr. 2017; 130(1-2):37-44.

PMID: 28752349 DOI: 10.1007/s00508-017-1240-9.

Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Vieira D, Gamarra L Int J Nanomedicine. 2016; 11:5381-5414.

PMID: 27799765 PMC: 5077137. DOI: 10.2147/IJN.S117210.

Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

Edagwa B, Zhou T, McMillan J, Liu X, Gendelman H Curr Med Chem. 2014; 21(36):4186-98.

PMID: 25174930 PMC: 4281174. DOI: 10.2174/0929867321666140826114135.

References

Brightman M, Broadwell R . The morphological approach to the study of normal and abnormal brain permeability. Adv Exp Med Biol. 1976; 69:41-54. DOI: 10.1007/978-1-4684-3264-0_4. View

Mayer L, Hope M, Cullis P, Janoff A . Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta. 1985; 817(1):193-6. DOI: 10.1016/0005-2736(85)90084-7. View

Laham A, Claperon N, Durussel J, Fattal E, Delattre J, Puisieux F . Liposomally-entrapped ATP: improved efficiency against experimental brain ischemia in the rat. Life Sci. 1987; 40(20):2011-6. DOI: 10.1016/0024-3205(87)90292-x. View

Gabizon A, Papahadjopoulos D . Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A. 1988; 85(18):6949-53. PMC: 282096. DOI: 10.1073/pnas.85.18.6949. View

RECKNAGEL R, Glende Jr E . Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol. 1984; 105:331-7. DOI: 10.1016/s0076-6879(84)05043-6. View

Fresta M, Puglisi G, Di Giacomo C, Russo A . Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion. J Pharm Pharmacol. 1994; 46(12):974-81. DOI: 10.1111/j.2042-7158.1994.tb03252.x. View

Puglisi G, Fresta M, La Rosa C, Ventura C, Panico A, Mazzone G . Liposomes as a potential drug carrier for citicoline (CDP-choline) and the effect of formulation conditions on encapsulation efficiency. Pharmazie. 1992; 47(3):211-5. View

Schwartz M, McConnell H . Surface areas of lipid membranes. Biochemistry. 1978; 17(5):837-40. DOI: 10.1021/bi00598a014. View

Siesjo B, Smith M . The biochemical basis of ischemic brain lesions. Arzneimittelforschung. 1991; 41(3A):288-92. View

10.

Arienti G, Corazzi L, Mastrofini P, MONTANINI I, Tirillini B, Porcellati G . Involvement of CDP-choline in phospholipid metabolism of brain tissue in vitro. Ital J Biochem. 1979; 28(1):39-45. View

11.

Long C, Staples D . Chromatographic separation of brain lipids: cerebroside and sulphatide. Biochem J. 1961; 78(1):179-85. PMC: 1205193. DOI: 10.1042/bj0780179. View

12.

Agut J, Font E, Sacristan A, Ortiz J . Bioavailability of methyl-14C CDP-choline by oral route. Arzneimittelforschung. 1983; 33(7A):1045-7. View

13.

Benita S, Poly P, Puisieux F, Delattre J . Radiopaque liposomes: effect of formulation conditions on encapsulation efficiency. J Pharm Sci. 1984; 73(12):1751-5. DOI: 10.1002/jps.2600731223. View

14.

Vanella A, Sorrenti V, Castorina C, Campisi A, Di Giacomo C, Russo A . Lipid peroxidation in rat cerebral cortex during post-ischemic reperfusion: effect of exogenous antioxidants and Ca(++)-antagonist drugs. Int J Dev Neurosci. 1992; 10(1):75-80. DOI: 10.1016/0736-5748(92)90008-n. View